  | | | | BRUSSELS/DUBLIN (Reuters) - EU antitrust regulators blocked Ryanair's third attempt to acquire Irish rival Aer Lingus on Wednesday, a ruling Europe's biggest low-cost airline called politically motivated and vowed to challenge in court. | | |  | | | | (Reuters) - Office Depot Inc's largest shareholder, Starboard Value LP, urged the stationery retailer to explore the sale of its Office Depot De Mexico joint venture interest. | | | |  | | | | BERLIN (Reuters) - EADS turned the page on a failed merger attempt with BAE Systems on Wednesday, saying a revival of the deal thwarted by German government opposition was not in its sights. | | | |  | | | | BRUSSELS (Reuters) - Russian oil producer Rosneft is expected to win unconditional European Union regulatory approval for its TNK-BP takeover bid, a source familiar with the matter said on Tuesday, taking it closer to completing the $55 billion deal. | | | |  | | | | (Reuters) - Tribune Co has hired investment banks Evercore Partners and J.P. Morgan to assess interest in its newspaper unit, which includes The Los Angeles Times and Chicago Tribune, the company confirmed in a statement on Tuesday. | | | |  | | | | NEW YORK (Reuters) - Juniper Networks Inc is reviewing its enterprise-focused networking business after talks fell through late last year to sell assets, including security unit NetScreen Technologies, several sources close to the matter told Reuters. | | | |  | | | | WASHINGTON (Reuters) - Executives from American Airlines and US Airways Group Inc on Tuesday faced gentle questions from lawmakers about their planned merger, with some expressing concern about losing hubs in their districts. | | | |  | | | | NEW DELHI/DUBAI (Reuters) - Abu Dhabi's Etihad Airways paid $70 million to buy Jet Airways' slots at London's Heathrow airport and said it remains in talks to buy a stake in the Indian carrier. | | | | | NEW YORK (Reuters) - Starwood Retail Properties is in talks to buy four lower sales- generating malls from Macerich Co , two sources familiar with the deal said on Tuesday. | | | | | | NEW YORK (Reuters) - New York-based investment firm Royalty Pharma does not want to take "no" for an answer to its $6.6 billion offer for Irish drugmaker Elan Corp . | | | |  |  | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | | |  | |  | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | | | | | | » MORE NEWSLETTERS | |
No comments:
Post a Comment